Company: Cipla Ltd. Category: IPO Notes


Cipla’s revenues of Rs40,075mn in 3QFY19 were up 2% YoY and down 1% QoQ and also below our/consensus estimate by 4.3%/2.7%, respectively.
Feb. 7, 2019, 11:30 a.m.
Publisher: nirmalbang.com

In line with our estimates, Cipla’s sales grew by 2% YoY, while EBITDA declined by 13.6% YoY in 3QFY19.
Feb. 7, 2019, 11 a.m.
Publisher: trade.rsec.co.in

Net Sales are expected to increase by 4.3 percent Y-o-Y (up 1.7 percent Q-o-Q) to Rs. 4,081.6 crore, according to ICICI Direct.
Jan. 11, 2019, 5:31 p.m.
Publisher: moneycontrol.com

Cipla has reported lower-than-expected performance in 2QFY19 with its revenue declining by 1.7% YoY (+1.9% QoQ) to Rs40.1bn led by muted to weak sales across geographies (barring the US) owing to high YoY base and challenging environment.
Nov. 12, 2018, 11:23 a.m.
Publisher: trade.rsec.co.in


Cipla’s revenue of Rs40,119mn in 2QFY19 were down 2% YoY and up 2% QoQ and below our/consensus estimates by 2.2%/6.5%, respectively.
Nov. 6, 2018, 11:24 a.m.
Publisher: nirmalbang.com

Cipla revenue grew by 11.7% YoY to Rs39.4bn (vs. estimates of Rs41bn) led by growth in domestic (22% YoY), South Africa (+23.2% YoY) and API biz (54% YoY).
Aug. 10, 2018, 10:26 a.m.
Publisher: trade.rsec.co.in

Cipla’s 1QFY19 revenues (Rs39,390mn) and net earnings (Rs4,510mn) were above consensus estimates led by an one-time extraordinary contingent payment of Rs 850mn (Chase Pharma Divestment) reported as other income.
Aug. 9, 2018, 10:22 a.m.
Publisher: nirmalbang.com

Cipla’s adj Sales, adj. EBITDA and PAT of Rs38.5bn, Rs6.3bn and Rs4.5bn were below our estimates by 7%, 21% and 3% respectively.
Aug. 8, 2018, 10:40 a.m.
Publisher: plindia.com

Cipla: 4QFY18 Result Update
May 23, 2018, 2:14 p.m.
Publisher: trade.rsec.co.in

Cipla : 4QFY18 Result Update
May 23, 2018, 2:10 p.m.
Publisher: nirmalbang.com

-->